Dividend stocks can be a great way to build long-term wealth, especially when you focus on companies that consistently raise their dividend payouts.
For long-term investors, holding reliable dividend stocks for a decade or more can mean steady income and fewer decisions to worry about. Especially in a world of short-term market noise, these kinds of businesses offer peace of mind and a clear path to financial freedom with the help of their dividends.
Here are 10 dividend stocks that look like solid buy-and-hold candidates for the next decade.
Find the best dividend stocks to buy today with TIKR (It’s free) >>>
Here are a few of our favorite stocks from this list:
UnitedHealth Group (UNH)
- Market Cap: $264 billion
- Industry: Health Care Providers and Services
- Analyst Upside: 52%
- P/E Ratio: 12
Company Overview: UnitedHealth Group Incorporated (UNH) is a leading U.S. healthcare conglomerate offering health insurance through UnitedHealthcare and healthcare services via Optum. It serves over 50 million people, making it the largest health insurer globally by revenue.
Business Strategy: UnitedHealth generates revenue through a diversified model: UnitedHealthcare provides health benefits, while Optum delivers services like pharmacy care, data analytics, and primary care. The company targets long-term earnings growth by expanding value-based care and driving operational efficiencies.
Why $UNH Could Be a Top Dividend Stock for the Next Decade:
- Strong Dividend Growth Track Record: UNH has a 15-year streak of dividend increases, boasting a 10-year compound annual growth rate of over 10%. Its consistent earnings growth has made those hikes possible year after year.
- Pullback May Offer Value: The stock has dropped significantly in recent months due to leadership changes and cost concerns. This could be an opportunity for long-term investors to buy a market leader at a discount.
- Financial Strength Backs Dividend Reliability: As the largest health insurer in the U.S., UNH generates steady cash flows from both insurance and healthcare services. That gives it the flexibility to keep rewarding shareholders.
Track UnitedHealth’s financials, growth trends, and analyst forecasts on TIKR >>>
WEC Energy Group (WEC)
- Market Cap: $33 billion
- Industry: Multi-Utilities
- Analyst Upside: 22%
- P/E Ratio: 22
Company Overview: WEC Energy Group (NYSE: WEC) is a diversified utility holding company headquartered in Milwaukee, Wisconsin. It provides electricity and natural gas to approximately 4.6 million customers across Wisconsin, Illinois, Michigan, and Minnesota.
Business Strategy: WEC generates revenue primarily through regulated utility operations, focusing on infrastructure modernization, renewable energy investments, and grid reliability. The company targets 6.5%–7% annual earnings growth, supported by a $28 billion five-year capital plan.
Why $WEC Could Be a Top Dividend Stock for the Next Decade:
- Reliable Dividends from a Utility Leader: WEC is a steady utility company that has raised its dividend consistently for many years. The nature of the utility business makes its cash flows predictable and stable.
- Attractive Yield with Room for Growth: The stock offers a solid dividend yield that stands out in today’s market. With a conservative payout policy, there’s room to increase it.
- Well-Positioned for the Long Run: WEC serves a growing population in the Midwest and is investing in cleaner energy infrastructure. That positions it well to keep delivering for both customers and investors.
Find stocks that are even better than WEC Energy Group today (It’s free) >>>
Johnson & Johnson (JNJ)
- Market Cap: $360 billion
- Industry: Pharmaceuticals
- Analyst Upside: 12%
- P/E Ratio: 14
Company Overview: Johnson & Johnson (NYSE: JNJ) is a global healthcare conglomerate with operations in pharmaceuticals, medical technologies, and consumer health. Following the 2023 spin-off of its consumer health division, Kenvue, its core business now focuses on innovative medicines and MedTech products.
Business Strategy: JNJ generates revenue primarily through its pharmaceutical segment, which targets high-growth therapeutic areas like oncology and immunology, and its medtech segment, which provides surgical and interventional solutions. The company is focused on driving innovation through R&D and strategic acquisitions while maintaining strong margins and global scale.
Why $JNJ Could Be a Top Dividend Stock for the Next Decade:
- Decades of Dividend Increases: JNJ is part of the exclusive group of companies that have raised their dividend for 63 straight years. That kind of consistency speaks to how resilient the business is.
- Diversified Business Model Supports Stability: With operations in pharmaceuticals, medical devices, and consumer health, JNJ isn’t overly dependent on any single segment. This helps smooth out performance and reduce risk.
- Valuation Looks Reasonable Today: After spinning off its consumer health segment, the stock has lagged behind the broader market. For long-term investors, this may be a good entry point into a blue-chip dividend name.
Analyze stocks like Johnson & Johnson quicker with TIKR >>>
TIKR Takeaway
The most dependable dividend stocks often combine consistent earnings, strong balance sheets, and shareholder-friendly policies.
These 10 companies have proven track records of rewarding investors, and many of them still look undervalued today.
- Looking for stocks with long-term growth potential? Browse TIKR’s stock screener to find the best stocks to buy today.
- Already love the stocks you own? Get real-time news and in-depth stock insights when you add your holdings to your watchlist on TIKR.
- Want to stay ahead? TIKR’s analysts’ estimates give you 5 years of Wall Street forecasts so you can feel confident in the stocks you invest in.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
